Organization
Skin Cancer Center, University Hospital Leipzig
4 abstracts
Abstract
Phase 3 study (PIVOTAL) of neoadjuvant intralesional daromun vs. immediate surgery in fully resectable melanoma with regional skin and/or nodal metastases.Org: University Hospital Schleswig-Holstein, University Hospital Heidelberg, Skin Cancer Center, University Hospital Leipzig, University Hospital Carl Gustav Carus, Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases,
Abstract
Association of ultra-sensitive ctDNA assay to identify actionable variants and response to immune checkpoint inhibitor (ICI) therapy in metastatic melanoma.Org: Skin Cancer Center, University Hospital Leipzig, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany, Personalis, Inc.,
Abstract
EGFR expression and relapse in patients with melanoma receiving adjuvant PD-1-based immunotherapy.Org: Skin Cancer Center, University Hospital Leipzig, Department of Dermatology, Eberhard Karls University of Tuebingen, Tübingen, Germany, Kantonsspital St. Gallen,
Abstract
Interim analysis of MelaRisk, a biomarker assay validation study in stage IB/IIA melanoma tissue.Org: Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany, Tübingen, Germany,